Indoleamine 2,3-Dioxygenase-1 Expression in Adrenocortical Carcinoma.

The Journal of Surgical Research
John F TierneyXavier M Keutgen

Abstract

Indoleamine 2,3-dioxygenase 1 (IDO-1) is overexpressed in many human carcinomas and a successful target for therapy in mouse models. Prognosis of patients with advanced adrenocortical carcinoma (ACC) is poor due to the lack of effective treatments, and new therapies are therefore needed. Herein, we investigate whether IDO-1 is expressed in human ACC tissues. 53 tissue samples from patients with ACC, adrenal adenoma (AA), adrenocortical tumors (ACTs), and normal adrenal were identified. Immunohistochemistry was performed on formalin-fixed, paraffin-embedded slides for IDO-1. Samples were scored for cytoplasmic staining as per intensity and the percent of positive cells and for stromal staining by percent of positive cells. Tumor characteristics, PD-L1, PDL-2, and CD-8+ T-lymphocyte expression were also determined. Samples from 32 ACC, 3 ACT, 15 AA, and 3 normal adrenal were analyzed. IDO-1 was expressed in tumor tissue in 22 of 32 ACC samples, compared with 8 of 15 AA sample (P = 0.344). IDO-1 expression was significantly increased in stromal tissue of ACC samples (16 of 33), compared with AA samples (0 of 15) (P = 0.001). IDO-1 expression in ACC and AA samples was associated with PD-L2 expression (P = 0.034). IDO-1 expression i...Continue Reading

References

Sep 5, 2002·International Journal of Cancer. Journal International Du Cancer·Maria FribergScott J Antonia
Apr 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yuichiro OhigashiYoshiyuki Nakajima
May 9, 2006·World Journal of Surgery·Electron KebebewAlex McMillan
Nov 23, 2006·British Journal of Cancer·K InoF Kikkawa
May 4, 2012·The New England Journal of Medicine·Martin FassnachtUNKNOWN FIRM-ACT Study Group
Oct 3, 2013·European Journal of Endocrinology·Montserrat Ayala-RamirezMouhammed Amir Habra
Apr 2, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·M T Isla LarrainM V Croce
Aug 6, 2015·International Journal of Hematology·Nobuhiko NakamuraHisashi Tsurumi
Jul 22, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kurt A SchalperDavid L Rimm
Jun 18, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jennifer H YearleyTerrill McClanahan
Oct 19, 2017·Journal for Immunotherapy of Cancer·Daniel E Carvajal-HausdorfDavid L Rimm
Dec 17, 2017·Cancer Research·George C PrendergastAlexander J Muller
Nov 8, 2018·Endocrine Connections·Deborah CosentiniAlfredo Berruti

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.